top of page
Search
Aalto Bio Reagents Acquired by Biosynth Carbosynth to Strengthen its Global Life Science Enterprise
Urs Spitz (left) – CEO and President, Biosynth Carbosynth and Philip Noone (right) – CEO, Aalto Bio Reagents Dublin, 25 May 2022 - Aalto...
Kellie Meade
May 25, 20222 min read
1,256 views
0 comments
Aalto Bio Reagents Launches New Recombinant Mayaro Virus E2 Gylcoprotein, Domain A.
Dublin, Ireland – May 11th 2022 – Aalto Bio Reagents Ltd., a leading global developer of critical raw materials for the development of...
Kellie Meade
May 11, 20223 min read
140 views
0 comments
Aalto Bio Reagents Announces 15 Pathogen Development Strategy to Solve the World's Future Diseases
Aalto Bio Reagents Ltd., a leading global developer of critical raw materials and reagents for the development of diagnostic tests, today...
Rachel O'Reilly
Apr 4, 20223 min read
276 views
0 comments
Aalto Bio Reagents Announces its New SARS-CoV-1 Spike Protein S1 Domain (Korean Outbreak Strain)
Dublin, Ireland – February 2nd 2022 – Aalto Bio Reagents ltd. a leading developer of critical raw materials and reagents for the...
Rory Quirkie
Feb 2, 20222 min read
98 views
0 comments
bottom of page